Pediatrics

Earlier pediatrics updates

• AAP evidence review examines UTI treatment duration, route, and prophylaxisOct 1, 2026
• AAP updates UTI guideline for infants and young childrenOct 1, 2026
• Permissive blood pressure targets show no mortality benefit in pediatric ICU trialSep 28, 2026
• Childhood and young adult cancer survivors show doubled cardiovascular riskSep 28, 2026
• Class II recall: Safecor Health, LLC: Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, Delivers: 10 mL, Oral Elixir, PAI, Sep 23, 2026
• Class II recall: Safecor Health, LLC: Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI,Sep 23, 2026
• Class II recall: Safecor Health, LLC: Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI,Sep 23, 2026
• Class II recall: Safecor Health, LLC: Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI,Sep 23, 2026
• Class II recall: Pfizer: Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tSep 23, 2026
• Class I recall: VITRUVIAS THERAPEUTICS INC: Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4Sep 23, 2026
• CDS Alert Sustains Shorter Antibiotic Courses for Pediatric SSTISep 17, 2026
• Blinatumomab cycles improve event-free survival in high-risk pediatric ALLSep 17, 2026
• Class I recall: B BRAUN MEDICAL INC: 0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB ContainerSep 16, 2026
• Class I recall: American Regent, Inc.: Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx OSep 16, 2026
• Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare CorporatSep 16, 2026
• Pediatric Firearm ED Visits Rose During Pandemic, Stayed Elevated Through 2023Sep 14, 2026
• Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 uSep 9, 2026
• Class II recall: Baxter Healthcare Corporation: Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100Sep 9, 2026
• Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 Sep 9, 2026
• Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY SinSep 9, 2026
• Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY Sep 9, 2026
• Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GSep 9, 2026
• Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Sep 2, 2026
• Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bSep 2, 2026
• Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx OnlSep 2, 2026
• Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx OnlSep 2, 2026
• Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count botSep 2, 2026
• Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx OnlSep 2, 2026
• Class II recall: American Regent, Inc.: ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR Aug 26, 2026
• Class II recall: American Regent, Inc.: Cyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Aug 26, 2026
• Class II recall: American Regent, Inc.: Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packAug 26, 2026
• Class II recall: American Regent, Inc.: Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged inAug 26, 2026
• Class II recall: Regeneron Pharmaceuticals Inc: Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous InfAug 26, 2026
• Class I recall: Fresenius Kabi USA, LLC: Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled sAug 26, 2026
• Class II recall: Heritage Pharmaceuticals Inc: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only,Aug 19, 2026
• Class II recall: Apollo Care, LLC: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For SubAug 19, 2026
• Class II recall: Apollo Care, LLC: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For SubcutAug 19, 2026
• Class II recall: Apollo Care, LLC: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose VAug 19, 2026
• Class I recall: Baxter Healthcare Corporation: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose InfusiAug 19, 2026
• Class I recall: Victory Medical Center Pharmacy: Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, AAug 19, 2026